48 related articles for article (PubMed ID: 7562912)
1. erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships.
Schnur RC; Corman ML; Gallaschun RJ; Cooper BA; Dee MF; Doty JL; Muzzi ML; DiOrio CI; Barbacci EG; Miller PE
J Med Chem; 1995 Sep; 38(19):3813-20. PubMed ID: 7562912
[TBL] [Abstract][Full Text] [Related]
2. Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.
Ochel HJ; Eichhorn K; Gademann G
Cell Stress Chaperones; 2001 Apr; 6(2):105-12. PubMed ID: 11599571
[No Abstract] [Full Text] [Related]
3. Cascade Transformation of the Ansamycin Benzoquinone Core into Benzoxazole Influencing Anticancer Activity and Selectivity.
Skrzypczak N; Pyta K; Bohusz W; Leśniewska A; Gdaniec M; Ruszkowski P; Schilf W; Bartl F; Przybylski P
J Org Chem; 2023 Jul; 88(13):9469-9474. PubMed ID: 37276434
[TBL] [Abstract][Full Text] [Related]
4. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy.
Kim JW; Cho YB; Lee S
Cells; 2021 Mar; 10(3):. PubMed ID: 33802964
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of paramagnetic ligands that target the C-terminal binding site of Hsp90.
Birar VC; Gelis I; Zuo A; Blagg BSJ
Bioorg Med Chem Lett; 2020 Aug; 30(16):127303. PubMed ID: 32631523
[TBL] [Abstract][Full Text] [Related]
6. Molecular insights into the interaction of Hsp90 with allosteric inhibitors targeting the C-terminal domain.
Kumar Mv V; Ebna Noor R; Davis RE; Zhang Z; Sipavicius E; Keramisanou D; Blagg BSJ; Gelis I
Medchemcomm; 2018 Aug; 9(8):1323-1331. PubMed ID: 30151087
[TBL] [Abstract][Full Text] [Related]
7. Biological and Chemical Diversity of Bacteria Associated with a Marine Flatworm.
Lin HN; Wang KL; Wu ZH; Tian RM; Liu GZ; Xu Y
Mar Drugs; 2017 Sep; 15(9):. PubMed ID: 28862674
[TBL] [Abstract][Full Text] [Related]
8. Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?
Khandelwal A; Crowley VM; Blagg BSJ
Med Res Rev; 2016 Jan; 36(1):92-118. PubMed ID: 26010985
[TBL] [Abstract][Full Text] [Related]
9. The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.
Brandvold KR; Morimoto RI
J Mol Biol; 2015 Sep; 427(18):2931-47. PubMed ID: 26003923
[TBL] [Abstract][Full Text] [Related]
10. Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells.
Boridy S; Le PU; Petrecca K; Maysinger D
Cell Death Dis; 2014 May; 5(5):e1216. PubMed ID: 24810052
[TBL] [Abstract][Full Text] [Related]
11. An improved route to 19-substituted geldanamycins as novel Hsp90 inhibitors--potential therapeutics in cancer and neurodegeneration.
Kitson RR; Moody CJ
Chem Commun (Camb); 2013 Oct; 49(76):8441-3. PubMed ID: 23770604
[TBL] [Abstract][Full Text] [Related]
12. Identification, design and bio-evaluation of novel Hsp90 inhibitors by ligand-based virtual screening.
Jia J; Xu X; Liu F; Guo X; Zhang M; Lu M; Xu L; Wei J; Zhu J; Zhang S; Zhang S; Sun H; You Q
PLoS One; 2013; 8(4):e59315. PubMed ID: 23565147
[TBL] [Abstract][Full Text] [Related]
13. ATP analog enhances the actions of a heat shock protein 90 inhibitor in multiple myeloma cells.
Cervantes-Gomez F; Nimmanapalli R; Gandhi V
J Pharmacol Exp Ther; 2011 Nov; 339(2):545-54. PubMed ID: 21821695
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Activity of Geldanamycin Derivatives against Schistosoma japonicum and Brugia malayi.
Wenkert D; Ramirez B; Shen Y; Kron MA
J Parasitol Res; 2010; 2010():716498. PubMed ID: 21253549
[TBL] [Abstract][Full Text] [Related]
15. Macrocyclic inhibitors of hsp90.
Johnson VA; Singh EK; Nazarova LA; Alexander LD; McAlpine SR
Curr Top Med Chem; 2010; 10(14):1380-402. PubMed ID: 20536417
[TBL] [Abstract][Full Text] [Related]
16. To fold or not to fold: modulation and consequences of Hsp90 inhibition.
Peterson LB; Blagg BS
Future Med Chem; 2009 May; 1(2):267-83. PubMed ID: 20161407
[TBL] [Abstract][Full Text] [Related]
17. Characterization of celastrol to inhibit hsp90 and cdc37 interaction.
Zhang T; Li Y; Yu Y; Zou P; Jiang Y; Sun D
J Biol Chem; 2009 Dec; 284(51):35381-9. PubMed ID: 19858214
[TBL] [Abstract][Full Text] [Related]
18. Withaferin A targets heat shock protein 90 in pancreatic cancer cells.
Yu Y; Hamza A; Zhang T; Gu M; Zou P; Newman B; Li Y; Gunatilaka AA; Zhan CG; Sun D
Biochem Pharmacol; 2010 Feb; 79(4):542-51. PubMed ID: 19769945
[TBL] [Abstract][Full Text] [Related]
19. Natural product inhibitors of Hsp90: potential leads for drug discovery.
Amolins MW; Blagg BS
Mini Rev Med Chem; 2009 Feb; 9(2):140-52. PubMed ID: 19200020
[TBL] [Abstract][Full Text] [Related]
20. Discovery and development of heat shock protein 90 inhibitors.
Taldone T; Sun W; Chiosis G
Bioorg Med Chem; 2009 Mar; 17(6):2225-35. PubMed ID: 19017562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
